| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 01/12/2005 | EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity |
| 01/12/2005 | EP1494671A1 1-(4-piperidinyl)benzimidazolones as histamine h3 antagonists |
| 01/12/2005 | EP1494670A1 Medicine for treating cancer |
| 01/12/2005 | EP1494668A2 Use of benzimidazole analogs in the treatment of cell proliferation |
| 01/12/2005 | EP1494663A1 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss |
| 01/12/2005 | EP1434773A4 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 01/12/2005 | EP1355906B1 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 01/12/2005 | EP0991628B1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR P56lck TYROSINE KINASES |
| 01/12/2005 | CN1564820A Heterocyclic compounds for use in the treatment of disorders of the urinary tract |
| 01/12/2005 | CN1564814A Triazine compounds, polymers comprising triazine structural units, and processes for the preparation of these polymers |
| 01/12/2005 | CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase |
| 01/12/2005 | CN1564685A Pyrrolidinone derivatives |
| 01/12/2005 | CN1563001A Method for preparing terazosin hydrochloride of optical activity |
| 01/12/2005 | CN1563000A Xinduo antibiotic, preparation method, and produced pesticide for preventing and curing damage of crop |
| 01/12/2005 | CN1184206C Prepn process of pyrazole derivative |
| 01/12/2005 | CN1184204C Piperidine compounds for use as CCR-3 inhibitors |
| 01/12/2005 | CN1183907C Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
| 01/11/2005 | US6841684 Imidiazoles having reduced side effects |
| 01/11/2005 | US6841680 2-(Halophenyl)-quinoline derivatives for neuropathic pain; side effect reduction |
| 01/11/2005 | US6841674 N-heterocyclic derivatives as NOS inhibitors |
| 01/11/2005 | US6841673 Enzyme inhibitors; antiinflammatory agents; rheumatic diseases; antidiabetic agents |
| 01/11/2005 | US6841670 Biphenyl-substituted triazines |
| 01/11/2005 | US6841566 Viral polymerase inhibitors |
| 01/11/2005 | US6841560 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 01/11/2005 | US6841552 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders |
| 01/06/2005 | WO2005000839A1 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | WO2005000838A1 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 01/06/2005 | WO2005000837A1 Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists |
| 01/06/2005 | WO2005000822A1 N-{‘4-substituted piperazine-1-sulfonylmethyl!alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | WO2005000821A1 Tachykinin receptor antagonists |
| 01/06/2005 | WO2005000817A2 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 01/06/2005 | WO2005000813A1 Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors |
| 01/06/2005 | WO2005000811A1 3-aminopyrrolidines as inhibitors of monoamine uptake |
| 01/06/2005 | WO2005000781A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | WO2005000353A1 Serum cholesterol lowering agnet or preventive or therapeutic agent for atherosclerosis |
| 01/06/2005 | WO2005000305A1 3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake |
| 01/06/2005 | WO2005000249A2 Preparation of chemical compounds |
| 01/06/2005 | WO2005000233A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 01/06/2005 | WO2004103977A3 Process for the preparation of pyrimidine derivatives |
| 01/06/2005 | WO2004101528A3 Isoquinoline derivatives and their use as gfat inhibitors |
| 01/06/2005 | WO2004099193A3 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions comprising the same and use thereof |
| 01/06/2005 | WO2004089947A3 Novel compounds having an antibacterial activity |
| 01/06/2005 | WO2004076445A3 Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 01/06/2005 | WO2004037166A3 Therapeutic guanidines |
| 01/06/2005 | WO2003032912A9 Treatment of cns disorders using cns target modulators |
| 01/06/2005 | US20050004367 Sulfonamide derivatives |
| 01/06/2005 | US20050004360 Compounds and methods for modulation of estrogen receptors |
| 01/06/2005 | US20050004206 suspending crystal strutured or amorphous lipitor in diluents comprising alcohols and/or water mixtures to cause conversion, then separating the diluents; monodispersity |
| 01/06/2005 | US20050004204 2-Iminopyrrolidine derivatives |
| 01/06/2005 | US20050004202 Such as 3-[1-(3-methoxypropyl )-1H-indazol-3-yl]-4-[1-(3-pyridinyl )-1H-indol-3-yl]-1H-pyrrole-2,5-dione; protein kinase C and/or glycogen synthase kinase-3 diseases |
| 01/06/2005 | US20050004200 Pyrazole compounds as integrin receptor antagonists derivatives |
| 01/06/2005 | US20050004197 Thrombin receptors antagonists; oral efficacy |
| 01/06/2005 | US20050004180 Conditions mediated by beta chemokine receptor 2, monocyte chemotactic protein 1 and/or their interaction; such as 4-acetyl-5-cyclohexyl-3-amino-1-(4-methylphenyl)-1,5-dihydro-2H-pyrrol-2-one |
| 01/06/2005 | US20050004176 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/06/2005 | US20050004166 Imino acid derivatives as inhibitors of matrix metalloproteinases |
| 01/06/2005 | US20050004162 Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use |
| 01/06/2005 | US20050004152 Thiazole compounds useful as inhibitors of protein kinase |
| 01/06/2005 | US20050004151 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators |
| 01/06/2005 | US20050004149 Pyrimidine compound and medicinal composition thereof |
| 01/06/2005 | US20050004148 Human immunodeficiency and hepatitis B infections; high activity, low toxicity |
| 01/06/2005 | US20050004136 Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful as neurokinin receptor modulators |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004126 Method of determining potential allosterically-binding matrix metalloproteinase inhibitors |
| 01/06/2005 | US20050004125 Such as 4-[[4-(1-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]-benzonitrile; bipolar disorder, pain, type 2 diabetes |
| 01/06/2005 | US20050004124 Synergistic mixture; antidiabetic agents; antiischemic agents |
| 01/06/2005 | US20050004119 Trypsin like serine protease enzyme inhibitors |
| 01/06/2005 | US20050004116 Triazole inhibitors of type 2 methionine aminopeptidase |
| 01/06/2005 | US20050004114 Heterocycle substituted carboxylic acids |
| 01/06/2005 | US20050004112 C-fms kinase inhibitors |
| 01/06/2005 | US20050004111 Degenerative joints disease; osteoarthritis |
| 01/06/2005 | US20050004110 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 01/06/2005 | US20050004109 Methods and compositions for the treatment and prevention of tumors, tumor-related disorders and cachexia |
| 01/06/2005 | US20050004104 Methods for the protection of memory and cognition |
| 01/06/2005 | US20050004103 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/06/2005 | US20050004097 Indole derivatives |
| 01/06/2005 | US20050004096 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 01/06/2005 | US20050004081 Pharmaceutical combinations for the treatment of cancer |
| 01/06/2005 | US20050004078 Nucleotide analogs with six-membered rings |
| 01/06/2005 | US20050003232 Quinoxaline derivatives, organic semiconductor device and electroluminescent device |
| 01/06/2005 | CA2672071A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2531020A1 Cannabinoid receptor modulator |
| 01/06/2005 | CA2530581A1 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 01/06/2005 | CA2530377A1 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 01/06/2005 | CA2529875A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | CA2529468A1 N-{[4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
| 01/06/2005 | CA2528619A1 Diphenylpyridine derivatives, preparation and therapeutic application thereof |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493743A1 Substituted bipiperidine intermediates and derivatives thereof |
| 01/05/2005 | EP1493733A2 Fungicidal heterocyclic aromatic amides, their compositions and methods of use |
| 01/05/2005 | EP1493057A1 Colour photographic recording material |
| 01/05/2005 | EP1492786A1 Pyridinoylpiperidines as 5-ht1f agonists |
| 01/05/2005 | EP1492785A1 New compounds |
| 01/05/2005 | EP1492771A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 01/05/2005 | EP1492765A2 Novel gamma secretase inhibitors |
| 01/05/2005 | EP1492571A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 01/05/2005 | EP1492568A1 Cancer treatment method comprising administration of an erb-family inhibitor and a raf and/or ras inhibitor |
| 01/05/2005 | EP1492536A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 01/05/2005 | EP1492526A2 Improved prodrugs of cc-1065 analogs |
| 01/05/2005 | EP1492487A2 Mitotic kinesin inhibitors |
| 01/05/2005 | EP1226126B1 Pyrimidine derivatives |